Preventive non–pharmacological treatment and nitric oxide in chronic migraine by unknown
Objectives
The International Classification of Headache Disorders,
2nd edition, codifies Chronic migraine (1.5.1) as a new
pathological entity, occurring 15 or more days per month,
for more than 3 months, in the absence of medication
overuse [1]. Chronic pain is related to central sensitisation
and is mediated by excitatory amino acids, neurokinins and
by nitric oxide (NO), involved in the regulation of the cere-
bral vessels tone. NO may function as a signalling molecule
in controlling neuronal activity and is crucial in controlling
signal-to-noise sensory inputs during migraine attack and
interacting with oxygen free radicals, which may cause
headache through variations of cerebral blood flow [2–4]. A
preventive non-pharmacologic treatment such as biofeed-
back, inducing the patients to detect and interact with psy-
chologic processes, may prove effective in decreasing the
disability and improving quality of life of patients with
chronic headache [5]. We investigated whether the efficacy
of biofeedback might be related to relaxation processes and
its influence on NO serum concentration.
Methods
Twenty patients with chronic migraine (mean age±SD: 25.6±4.6
years) were examined. Chronic migraine was diagnosed accord-
ing to the criteria of the Headache Classification Subcommittee
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Abstract In chronic migraine the
central sensitisation and the
changes of regional cerebral blood
flow are mediated by nitric oxide
(NO) and oxygen free radicals.
Biofeedback is considered a pre-
ventive non-pharmacological treat-
ment decreasing migraine attacks.
We investigated whether biofeed-
back effectiveness is related to
relaxation processes and its influ-
ence on oxidative stress. The
Migraine Disability Assessment
Score (MIDAS) and serum NO sta-
ble metabolites (NOx) were evaluat-
ed in 20 patients with chronic
migraine before and at the end of
biofeedback sessions. MIDAS score
was lower after biofeedback than
that reported before treatment. NOx
serum levels were higher after
biofeedback than those measured
before starting treatment. Thus, the
effectiveness of biofeedback is
related to a muscular relaxation and
to its influence on NO bioavailabil-
ity in patients with chronic
migraine.
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of the International Headache Society. Headache disability were
evaluated by the Migraine Disability Assessment Score
(MIDAS), administered before and after the biofeedback treat-
ment sessions. No pharmacological preventive treatment was per-
mitted during the study. Patients were allowed to treat migraine
headache if pain was so severe as to compromise daily activity.
We suggested the use of indomethacin at a maximum of 50
mg/day. For the biofeedback session we used the Satem
Myoexpand Series 400, EMG Module M3. Three circular metal
electrodes were applied to the frontal muscle. Migraine sufferers
underwent three sessions of biofeedback per week for a total of
12 sessions. Each biofeedback session lasted 20 min. Serum sam-
ples collected before and after biofeedback sessions were assayed
for NO stable metabolites (NOx). NOx were measured by reduc-
ing nitrate to nitrite and measuring nitrite by a sensitive fluori-
metric assay based on the reaction of nitrite with 2,3-diaminon-
aphthalene to form the fluorescent product 1-(H)-naphthotria-
zole. Intensity of the fluorescent signal of the samples was mea-
sured and compared with known concentrations of sodium nitrite
(excitation wavelength 375 nm, emission wavelength 415 nm).
Results
MIDAS scores of migraine attacks after biofeedback-
assisted relaxation training were lower with respect to
those reported before (36.9±13.9 vs. 18.8±10.4, p<0.001).
NOx serum levels were higher after biofeedback training
sessions than those measured before (31.3±7.1 vs.
23.7±4.2 µM, p<0.001).
Discussion
Biofeedback-assisted relaxation training is a non-invasive
behavioural treatment with good compliance in migraine
sufferers and without adverse events. This mind-body
technique may help to treat a wide range of mental and
physical health problems controlling involuntary body
responses such as blood pressure, heart rate and muscle
tension. The effectiveness of behavioural interventions is
related to making patients aware of their bodies’ physio-
logic responses, reducing anxiety and depression and
inducing a muscular relaxation [6, 7]. After the biofeed-
back sessions we observed an increase in NO bioavail-
ability. NO synthesised by the constitutive enzyme medi-
ates mainly physiological effects, whereas the expression
of inducible NO synthases may lead to a sizeable NO
bioavailability associated with cytotoxic effects. The
relaxation therapies may be considered useful in decreas-
ing chronic pain activating only constitutive NO path-
ways. Therefore, the effectiveness of behavioural inter-
ventions such as biofeedback in limiting migraine attacks
may be related to a reduction of muscular relaxation and
to an increase of NO bioavailability.
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